North Star Asset Management Inc Biogen Inc. Transaction History

North Star Asset Management Inc

$2.03 Billion
Q1 2024

A detailed history of North Star Asset Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, North Star Asset Management Inc holds 943 shares of BIIB stock, worth $215,070. This represents 0.01% of its overall portfolio holdings.

Number of Shares

943

Previous 913 3.29%

Holding current value

$215,070

Previous $236,000 13.98%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $6,360 - $8,031	30 Added 3.29%	943 $203,000
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $1,773 - $2,001	-7 Reduced 0.76%	913 $234,000
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $15,138 - $17,493	-55 Reduced 5.64%	920 $262,000
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $9,236 - $10,524	-36 Reduced 3.56%	975 $271,000
Q4 2022 Mar 06, 2023	SELL	$252.44 - $306.72 $5,301 - $6,441	-21 Reduced 2.03%	1,011 $279,000

Q2 2022 Jul 28, 2022	BUY	$187.54 - $223.02 $1,875 - $2,230	10 Added 0.98%	1,032 $210,000
Q3 2021 Oct 20, 2021	SELL	$282.99 - $369.05 $14,149 - $18,452	-50 Reduced 4.66%	1,022 $289,000
Q2 2021 Jul 30, 2021	SELL	$259.0 - $414.71 $58,275 - $93,309	-225 Reduced 17.35%	1,072 $371,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $47,252 - $71,126	-200 Reduced 13.36%	1,297 $318,000
Q1 2020 Apr 24, 2020	SELL	$268.85 - $341.04 $94,097 - $119,364	-350 Reduced 18.95%	1,497 $473,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $10,964 - $12,086	-50 Reduced 2.64%	1,847 $432,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $144,211 - $171,869	-560 Reduced 22.79%	1,897 $551,000
Q1 2018 Apr 27, 2018	SELL	$260.13 - $367.91 $46,823 - $66,223	-180 Reduced 6.83%	2,457 $673,000
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $605,743 - $678,478	1,969 Added 294.76%	2,637 $840,000
Q3 2017 Oct 25, 2017	BUY	$281.15 - $329.69 $187,808 - $220,232	668	668 $209,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.

Account

North Star Asset Management Inc Biogen Inc. Transaction History